150 likes | 170 Views
Join us for an intensive 3-day training session on pharmaceutical quality assessment and guidelines, covering key areas such as impurities, methods validation, dissolution, stability, and more. Gain insights into new quality guidelines implemented by WHO/PQP and learn how to address common deficiencies. Interactive sessions and expert feedback provided. Become adept in assessing production documents and recognizing red flags in quality assessment.
E N D
Quality WorkshopCopenhagen – January 2011 Training session Outline and Objectives
Outline – Day 1 General talks: Prequalification of Medicines Programme (PQP) The new WHO/PQP quality guidelines The new WHO/PQP quality templates
Outline – Day 1 continued Active Pharmaceutical Ingredient (API) talks: API assessment: Approaches and considerations Impurities: Establishing specifications (API and FPP) Finished Pharmaceutical Product (FPP) talks begin: Pharmaceutical development: ICH Q8 “minimal” approach
Outline – Day 2 FPP talks continue: Dissolution case studies Supporting documents for assessment – SUPAC FPP assessment: Approaches and considerations Method and validation basics – HPLC case study Formulation development issues for solid orals Stability
Outline – Day 3 Final general and FPP talks: GMP lessons for quality review Assessing production documents: executed and master records Breakout sessions begin.
Objectives General objectives Increase knowledgeof key quality areas: impurities, methods and their validation, dissolution, pharmaceutical development and stability. One-on-one feedback: provides a forum for individual questions to be answered by a senior assessor. Make note of any and all questions re PQP and quality assessment as they occur to you.
Objectives Providing insight into some commonly encountered deficiencies and how to deal with them. Specific objectives Introduction to the new quality guidelines and templates, and how these are being implemented in PQP.
Quality Assessment Manufacturing sciences Pharmaceutical engineering/pharmaceutical technology (production methods and systems, facilities, equipment, etc.) Pharmaceutical sciences Chemistry (organic, inorganic, physical, biochemical, analytical (e.g. methodology, validation, spectral analysis)) Pharmaceutical chemistry (study of drug design) Pharmaceutics (study of drug formulation) Pharmacognosy (study of drugs of natural origin) Other fields: Math/statistics, microbiology, GMP
Quality Assessment Quality assessment: Covers many fields of knowledge Complex (issues have multiple factors involved) Involves large amounts of data No two products are the same First assessment (and report!) of the original dossier is the most important part of the process.
Quality Assessment “… is a primeval jungle, an amazing thicket, without escape or end, into which one would not dare to enter” Friedrich Wöhler
Assessing smart • Critical thinking – how deeply to assess given data ► how important is this ► how does it relate to other data ► “less important” areas can be skimmed through BUT it is important to watch for red flags that require a closer look • Continually learning • Staying on top of guidelines and advances – e.g. Q&A docs